Medical University of South Carolina forges drug research venture with Aeterna Zentaris

A pharmaceutical company is transferring its library of 100,000 drug compounds to the Medical University of South Carolina, kicking off a collaborative venture that organizers hope will lead to new discoveries.

Aeterna Zentaris Inc. of Canada said the agreement represents the start of a long-term relationship with the South Carolina Center for Therapeutic Discovery & Development at MUSC.

The Quebec-based development-stage company will continue to have access to the collection for researching and developing potential treatments in the areas of oncology, neurology, endocrinology and women’s health.

Online Article on The Post and Courier